IBDEI0H9 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7717,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ focal & segmental glomerular lesions
 ;;^UTILITY(U,$J,358.3,7717,1,4,0)
 ;;=4^N05.1
 ;;^UTILITY(U,$J,358.3,7717,2)
 ;;=^5015542
 ;;^UTILITY(U,$J,358.3,7718,0)
 ;;=N05.2^^52^518^46
 ;;^UTILITY(U,$J,358.3,7718,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7718,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ diffuse membranous glomrlneph
 ;;^UTILITY(U,$J,358.3,7718,1,4,0)
 ;;=4^N05.2
 ;;^UTILITY(U,$J,358.3,7718,2)
 ;;=^5015543
 ;;^UTILITY(U,$J,358.3,7719,0)
 ;;=N05.3^^52^518^47
 ;;^UTILITY(U,$J,358.3,7719,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7719,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ diffuse mesangial prolif glomrlneph
 ;;^UTILITY(U,$J,358.3,7719,1,4,0)
 ;;=4^N05.3
 ;;^UTILITY(U,$J,358.3,7719,2)
 ;;=^5015544
 ;;^UTILITY(U,$J,358.3,7720,0)
 ;;=N05.4^^52^518^45
 ;;^UTILITY(U,$J,358.3,7720,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7720,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ diffuse endocaplry prolif glomrlneph
 ;;^UTILITY(U,$J,358.3,7720,1,4,0)
 ;;=4^N05.4
 ;;^UTILITY(U,$J,358.3,7720,2)
 ;;=^5015545
 ;;^UTILITY(U,$J,358.3,7721,0)
 ;;=N05.5^^52^518^48
 ;;^UTILITY(U,$J,358.3,7721,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7721,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ diffuse mesangiocap glomrlneph
 ;;^UTILITY(U,$J,358.3,7721,1,4,0)
 ;;=4^N05.5
 ;;^UTILITY(U,$J,358.3,7721,2)
 ;;=^5015546
 ;;^UTILITY(U,$J,358.3,7722,0)
 ;;=N05.6^^52^518^43
 ;;^UTILITY(U,$J,358.3,7722,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7722,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ dense deposit disease
 ;;^UTILITY(U,$J,358.3,7722,1,4,0)
 ;;=4^N05.6
 ;;^UTILITY(U,$J,358.3,7722,2)
 ;;=^5015547
 ;;^UTILITY(U,$J,358.3,7723,0)
 ;;=N05.7^^52^518^44
 ;;^UTILITY(U,$J,358.3,7723,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7723,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ diffuse crescentic glomrlneph
 ;;^UTILITY(U,$J,358.3,7723,1,4,0)
 ;;=4^N05.7
 ;;^UTILITY(U,$J,358.3,7723,2)
 ;;=^5015548
 ;;^UTILITY(U,$J,358.3,7724,0)
 ;;=N05.8^^52^518^51
 ;;^UTILITY(U,$J,358.3,7724,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7724,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ oth morphologic changes
 ;;^UTILITY(U,$J,358.3,7724,1,4,0)
 ;;=4^N05.8
 ;;^UTILITY(U,$J,358.3,7724,2)
 ;;=^5134085
 ;;^UTILITY(U,$J,358.3,7725,0)
 ;;=N05.9^^52^518^52
 ;;^UTILITY(U,$J,358.3,7725,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7725,1,3,0)
 ;;=3^Nephritic syndrome unspec w/ unspec morphologic changes
 ;;^UTILITY(U,$J,358.3,7725,1,4,0)
 ;;=4^N05.9
 ;;^UTILITY(U,$J,358.3,7725,2)
 ;;=^5134086
 ;;^UTILITY(U,$J,358.3,7726,0)
 ;;=N06.0^^52^518^40
 ;;^UTILITY(U,$J,358.3,7726,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7726,1,3,0)
 ;;=3^Isolated proteinuria w/ minor glomerular abnormality
 ;;^UTILITY(U,$J,358.3,7726,1,4,0)
 ;;=4^N06.0
 ;;^UTILITY(U,$J,358.3,7726,2)
 ;;=^5015549
 ;;^UTILITY(U,$J,358.3,7727,0)
 ;;=N06.1^^52^518^39
 ;;^UTILITY(U,$J,358.3,7727,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7727,1,3,0)
 ;;=3^Isolated proteinuria w/ focal & segmental glomerular lesions
 ;;^UTILITY(U,$J,358.3,7727,1,4,0)
 ;;=4^N06.1
 ;;^UTILITY(U,$J,358.3,7727,2)
 ;;=^5015550
 ;;^UTILITY(U,$J,358.3,7728,0)
 ;;=N06.2^^52^518^36
 ;;^UTILITY(U,$J,358.3,7728,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7728,1,3,0)
 ;;=3^Isolated proteinuria w/ diffuse membranous glomerulonephritis
 ;;^UTILITY(U,$J,358.3,7728,1,4,0)
 ;;=4^N06.2
 ;;^UTILITY(U,$J,358.3,7728,2)
 ;;=^5015551
 ;;^UTILITY(U,$J,358.3,7729,0)
 ;;=N06.3^^52^518^37
 ;;^UTILITY(U,$J,358.3,7729,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7729,1,3,0)
 ;;=3^Isolated proteinuria w/ diffuse mesangial prolif glomrlneph
